These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 35105626)

  • 1. Clinical efficacy of diquafosol sodium 3% versus hyaluronic acid 0.1% in patients with dry eye disease after cataract surgery: a protocol for a single-centre, randomised controlled trial.
    Miura M; Inomata T; Nojiri S; Sung J; Nagao M; Shimazaki J; Midorikawa-Inomata A; Okumura Y; Fujio K; Akasaki Y; Kuwahara M; Huang T; Nakamura M; Iwagami M; Hirosawa K; Fujimoto K; Murakami A
    BMJ Open; 2022 Jan; 12(1):e052488. PubMed ID: 35105626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Effects and Safety of 3% Diquafosol Ophthalmic Solution for Patients With Dry Eye After Cataract Surgery: A Randomized Controlled Trial.
    Park DH; Chung JK; Seo DR; Lee SJ
    Am J Ophthalmol; 2016 Mar; 163():122-131.e2. PubMed ID: 26685791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The feasibility of finger prick autologous blood (FAB) as a novel treatment for severe dry eye disease (DED): protocol for a randomised controlled trial.
    Balal S; Udoh A; Pappas Y; Cook E; Barton G; Hassan A; Hayden K; Bourne RRA; Ahmad S; Pardhan S; Harrison M; Sharma B; Wasil M; Sharma A
    BMJ Open; 2018 Oct; 8(10):e026770. PubMed ID: 30385451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of topical diquafosol for the treatment of dry eye disease: An updated meta-analysis of randomized controlled trials.
    Liu S; Yang G; Li Q; Tang S
    Indian J Ophthalmol; 2023 Apr; 71(4):1304-1315. PubMed ID: 37026262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and Safety of Topical 3% Diquafosol Ophthalmic Solution for the Treatment of Multifactorial Dry Eye Disease: Meta-Analysis of Randomized Clinical Trials.
    Nam K; Kim HJ; Yoo A
    Ophthalmic Res; 2019; 61(4):188-198. PubMed ID: 30654362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Effect of Topical Diquafosol Tetrasodium 3% on Dry Eye After Cataract Surgery.
    Baek J; Doh SH; Chung SK
    Curr Eye Res; 2016 Oct; 41(10):1281-1285. PubMed ID: 27049809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of rb-bFGF Eye Drops for Post-Cataract Surgery Dry Eye and Observation of Changes in Tear Secretion and Corneal Damage in Patients.
    Zhao X; Jia Q; Fu J
    Altern Ther Health Med; 2023 Nov; 29(8):489-495. PubMed ID: 37652420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of diquafosol tetrasodium 3% on the conjunctival surface and clinical findings after cataract surgery in patients with dry eye.
    Cui L; Li Y; Lee HS; Yang JM; Choi W; Yoon KC
    Int Ophthalmol; 2018 Oct; 38(5):2021-2030. PubMed ID: 28822028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomised, prospective study of the effects of 3% diquafosol on ocular surface following cataract surgery.
    Kim S; Shin J; Lee JE
    Sci Rep; 2021 Apr; 11(1):9124. PubMed ID: 33907267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of 3% diquafosol sodium eye drop application on meibomian gland and ocular surface alterations in the Cu, Zn-superoxide dismutase-1 (Sod1) knockout mice.
    Ikeda K; Simsek C; Kojima T; Higa K; Kawashima M; Dogru M; Shimizu T; Tsubota K; Shimazaki J
    Graefes Arch Clin Exp Ophthalmol; 2018 Apr; 256(4):739-750. PubMed ID: 29484560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A protocol for a single center, randomized, controlled trial comparing the clinical efficacy of 3% diquafosol and 0.1% hyaluronic acid in diabetic patients with dry eye disease.
    Chen J; Chen Y; Qin G; Li L; Li M; Cheng Y; Zhuang S; Li Z; Zhang Q; Wu Y; Yang L; Moutari S; Moore JE; Xu L; He W; Yu S; Pazo EE; He X
    Trials; 2023 Dec; 24(1):803. PubMed ID: 38087329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of diquafosol ophthalmic solution in patients with dry eye syndrome: a Japanese phase 2 clinical trial.
    Matsumoto Y; Ohashi Y; Watanabe H; Tsubota K;
    Ophthalmology; 2012 Oct; 119(10):1954-60. PubMed ID: 22739038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diquafosol ophthalmic solution 3 %: a review of its use in dry eye.
    Keating GM
    Drugs; 2015 May; 75(8):911-22. PubMed ID: 25968930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomised, parallel-group comparison study of diquafosol ophthalmic solution in patients with dry eye in China and Singapore.
    Gong L; Sun X; Ma Z; Wang Q; Xu X; Chen X; Shao Y; Yao K; Tang L; Gu Y; Yuan H; Chua WH; Chuan JC; Tong L
    Br J Ophthalmol; 2015 Jul; 99(7):903-8. PubMed ID: 25631485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Diquafosol Ophthalmic Solution on Tear Film and Dry Eye Symptom in Type 2 Diabetic Dry Eye: A Pilot Study.
    Zhang Q; Zhang H; Qin G; Wu Y; Song Y; Yang L; Yu S; He X; Moore JE; Moutari S; Palme C; Xu L; He W; Pazo EE
    J Ocul Pharmacol Ther; 2022 Mar; 38(2):133-140. PubMed ID: 35049373
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of Preservative-free 3% Diquafosol in Patients with Pre-existing Dry Eye Disease after Cataract Surgery: A Randomized Clinical Trial.
    Jun I; Choi S; Lee GY; Choi YJ; Lee HK; Kim EK; Seo KY; Kim TI
    Sci Rep; 2019 Sep; 9(1):12659. PubMed ID: 31477748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protocol for a parallel assignment prospective, randomised, comparative trial to evaluate the safety and efficacy of intense pulsed light (IPL) combined with 3% diquafosol (DQS) ophthalmic solution in dry eye syndrome.
    Chen J; Qin G; Li L; Qi Y; Che H; Huang H; Xia Y; Zhang Q; Wu Y; Yang L; Moutari S; Moore JE; Xu L; He W; Yu S; Pazo EE; He X
    BMJ Open; 2023 Aug; 13(8):e073055. PubMed ID: 37643847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of treatment efficacy between 100% platelet-rich plasma and 100% serum eye drops in moderate-to-severe dry eye disease: a randomised controlled trial protocol.
    Jongkhajornpong P; Numthavaj P; Anothaisintawee T; Lekhanont K; McKay G; Attia J; Thakkinstian A
    BMJ Open; 2021 Jun; 11(6):e048479. PubMed ID: 34193498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Additive Effect of preservative-free sodium hyaluronate 0.1% in treatment of dry eye syndrome with diquafosol 3% eye drops.
    Hwang HS; Sung YM; Lee WS; Kim EC
    Cornea; 2014 Sep; 33(9):935-41. PubMed ID: 25055152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the efficacy between topical diquafosol and artificial tears in the treatment of dry eye following cataract surgery: A meta-analysis of randomized controlled trials.
    Zhao X; Xia S; Chen Y
    Medicine (Baltimore); 2017 Sep; 96(39):e8174. PubMed ID: 28953672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.